Daniel K. currently serves as a Corporate Development Manager at Pfizer, focusing on mergers and acquisitions, licensing, and partnerships since November 2023. Prior to this role, Daniel worked as an Investment Banking Associate at Jefferies from January 2022 to August 2023, specializing in healthcare M&A. Daniel also held positions as an Investment Banking Associate at Oppenheimer & Co. Inc. between September 2020 and January 2022, and as an Investment Banking Analyst at Mizuho from July 2018 to September 2020, both within the healthcare sector. Daniel K. earned a Bachelor of Science in Business Administration with a concentration in Accounting and Finance from Georgetown University McDonough School of Business, completing studies in 2018.
This person is not in any teams
This person is not in any offices